3
Publications
89
Citations
3
H-Index
2017
Active since
Affiliations
Shiguang Cao is an author at Second Affiliated Hospital of Xi'an Jiaotong University specializing in tumor biology, lung cancer, and cancer research.
Top concepts
MedicineLung CancerTumor BiologyCancer BiologyCancer ResearchRadiation OncologyHealthPathologyCell BiologyCell Proliferation
Publications per year
2017–2021
3
3
RNA helicase DHX9 may be a therapeutic target in lung cancer and inhibited by enoxacin.
Shiguang Cao, Ruiying Sun, Wei Wang et al. · PubMed · 2017 · 43 citations · Full text
Rows per page
1–3 of 3